Ad
related to: neurodegenerative
Search results
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 7 days agoAlterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative</ ...
Dutch Bros hosting fundraiser to support ALS research
KGET Bakersfield via Yahoo News· 1 day agoBAKERSFIELD, Calif. (KGET) — Dutch Bros on Friday will host its 18th annual fundraiser in the fight...
This Common Cooking Ingredient Could Lower Your Risk of Dementia-Related Death, According to a New...
Men's Journal· 1 day agoDiet can play an integral part in fending off the development ofneurodegenerative disease later in...
Missouri Gay Rodeo inspires man with neurodegenerative disorder to overcome mobility challenges
KOMU Columbia· 14 hours agoSeven years ago, Malcolm Cook was diagnosed with spinocerebellar ataxia, a degenerative brain...
A promising new study could lead to a reduction in symptoms of amyotrophic lateral sclerosis (ALS)
The Conversation· 2 days agoEvery year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). As neuroscience researchers, we are dedicated to finding ways to ...
VidaCaixa creates a panel of experts for senior citizens
Hardwood Paroxysm· 6 days agoThe company, which increased its first-quarter earnings by 8%, to $298 million, commissioned this...
What Does a Lonely Brain Look Like?
New York Times· 6 days agoFeeling chronically disconnected from others can affect the brain’s structure and function, and it raises the risk for neurodegenerative diseases. It...
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
Digital Journal· 11 hours agoTop-line data from first-in-human Phase 1a clinical trial of PMN310 as a treatment for Alzheimer’s disease on track for mid-2024CAMBRIDGE, Massachusetts and TORONTO, Ontario, May 14, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a
Amylyx Pharmaceuticals Reports Q1 2024 Financial Results
Guru Focus· 4 days agoThe Cambridge, Massachusetts-based biopharmaceutical company, known for its focus on neurodegenerative diseases, reported a notable increase in revenue ...
Ultra-processed food leads to higher risk of early death, study shows
The Washington Times· 6 days agoA study published in The British Medical Journal Wednesday measuring the health of thousands of...